Blood Test May Detect Gallbladder Cancer Soon

Researchers identify distinct metabolic signatures in blood that could enable earlier diagnosis.

Published on Feb. 26, 2026

Got story updates? Submit your updates here. ›

Researchers at Tezpur University in India, working with scientists at the University of Illinois Urbana-Champaign, have identified unique chemical signatures in blood that could help detect gallbladder cancer earlier, including in patients with and without gallstones. The findings, published in the Journal of Proteome Research, point to specific metabolic patterns that distinguish gallbladder cancer cases from noncancerous conditions, offering a potential pathway toward noninvasive screening for this deadly gastrointestinal cancer.

Why it matters

Gallbladder cancer is a relatively rare but highly deadly disease, often not detected until advanced stages. This research could lead to the development of simple blood-based tests to enable earlier diagnosis, particularly in high-risk regions like northern India where gallbladder cancer is more common.

The details

The study analyzed blood samples from three groups: gallbladder cancer patients without gallstones, cancer patients with gallstones, and individuals with gallstones but no cancer. The researchers detected hundreds of altered metabolites and identified distinct markers within the blood samples that had high diagnostic accuracy for each condition. Many of the identified metabolites were linked to bile acids and amino acid derivatives known to play roles in tumor development and progression.

  • The study was published in the Journal of Proteome Research in February 2026.

The players

Tezpur University

A university in Assam, India, where the lead researchers Pankaj Barah and Cinmoyee Baruah are based.

University of Illinois Urbana-Champaign

The university where the Illinois collaborator Amit Rai, an assistant professor in the Department of Crop Sciences, led the computational metabolomics analysis.

Swagat Super Speciality and Surgical Hospital

The hospital where study co-author Subhash Khanna, a gastrointestinal surgeon, is based.

Got photos? Submit your photos here. ›

What they’re saying

“Once the raw data are generated, the real challenge is making biological sense of it. Properly annotating metabolites and analyzing their patterns is what allows us to move from signals in the data to meaningful insight about disease mechanisms.”

— Amit Rai, Assistant Professor, Department of Crop Sciences, University of Illinois Urbana-Champaign (Journal of Proteome Research)

“Our findings show that changes in certain blood metabolites can clearly distinguish gallbladder cancer cases with and without gallstones. This raises the possibility of developing simple blood-based tests that could support earlier diagnosis.”

— Pankaj Barah, Assistant Professor, Tezpur University (Journal of Proteome Research)

“Identifying blood-based metabolic markers provides a practical pathway toward earlier diagnosis and more informed clinical decision-making.”

— Subhash Khanna, Gastrointestinal Surgeon, Swagat Super Speciality and Surgical Hospital (Journal of Proteome Research)

What’s next

The researchers emphasize that larger, multicenter studies are needed before the findings can be used clinically, but the work lays out important groundwork for noninvasive screening tools, particularly in high-risk regions.

The takeaway

This research highlights the growing role of international collaborations in advancing cancer detection and diagnosis, and offers hope for the development of simple blood tests that could enable earlier diagnosis of gallbladder cancer, a deadly disease that is often detected too late.